ArticleBMJ open ophthalmology2019

Intravitreal bevacizumab improves the clearance of vitreous haemorrhage and visual outcomes in patients with proliferative diabetic retinopathy.

Joonas Wirkkala et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.